ãã®ãã¼ã ãã¼ã¸ããè±èªã»ä¸å½èªã»éå½èªã¸æ©æ¢°çã«èªå翻訳ãã¾ãã以ä¸ã®å 容ããç解ã®ããããå©ç¨ããã ãã¾ããããé¡ããã¾ãã 1.
äºé ¸åå¡©ç´ ï¼ã«ãããããããChlorine dioxideï¼ã¨ã¯å¡©ç´ ã®é ¸åç©ã§ãåå¦å¼ ClO2ã§è¡¨ãããç¡æ©ååç©ã§ãããå¡©ç´ ã®é ¸åæ°ã¯+4ã 常温ã常å§ã§ã¯å¡©ç´ ããªã¾ã³ã®ãããªåºæ¿èã®ããæ©è²ããé»è²ã§ç©ºæ°ããéãæ°ä½ã§ããããæ¿åº¦çã«ããèæ°ã»è²èª¿ã¯ç°ãªããå ãç±ã«å¯¾ãã¦ã¯ä¸å®å®ã液ä½ã¯èµ¤è¤è²ã§æ¯é 1.64ï¼0°Cï¼ãåºä½ã¯æ©é»è²ã溶解度 0.8g/100mLï¼20°Cï¼[1]ãå¡©ç´ ååä¸ã«ä¸å¯¾é»åããã¤ååï¼ã©ã¸ã«ã«ï¼ã§ãããåå¿æ§ãé«ãã å¡©ç´ é ¸ã«ããã®ä»ã®é ¸ã溶ããã¦å¾ãããã äºé ¸åå¡©ç´ ã®æ§é ã«é¢ããè«æ[2]ã«ããã¨æ¶²ä½äºé ¸åå¡©ç´ ã®æ§é ã¯å³å³ã®éãã 殺èä½ç¨ãããã殺èç®çã¨ãã¦æ°´ãæ¶æ¯ããã ãã§ãªãæ¶èç®çã®æ¶èæãªã©ã«ã使ããããããã ãã§ã¯ãªãã¡ã¿ã³ã®é ¸åç®çã«ã使ãããã ãã«ãã製é ããã¨ããç¹ç¶ã®æ¼ç½ã«ç¨ããããããã¤ã¦å¡©ç´ ã¬ã¹ãç¨ãããã¦ãããã®ããã»ã«
ãã¾ã @readeigo ä»æ¥èããæã話ãæ¥æ¬ã§ã¯åä¾ã®æ°ã¯æ¸ã£ã¦ãããã©ãä¸ç»æ ¡å ã®æ°ã¯å¢ãã¦ãããã ããå¦æ ¡ã«è¡ããªãåéãéããããªã¼ã¹ã¯ã¼ã«ãã¯å¢ãã¦ãããã©ãæ¿åºè¦å¶ããªãç¶æ ãªã®ã§ãåä¾ã«å®æãæ¿æ²»çãªææ³ãä¸ããã人éãè¨ç«ãã¦ããã±ã¼ã¹ãå¢ãã¦ãããããå·ã¤ããåã«ããã¯æ¬å½ã«å±éºã ãã¾ã @readeigo æ®éã®å¦æ ¡ã§ãå¥ã®ã³ãã¥ããã£ã§ãã©ãã§ãææ³ãå®æçã«å½±é¿ä¸ãããã¨ãã¦ããçµç¹ã¯å¤ãã§ãããæ¥ã¦ããåéã®å¾åãéãã®ã§å±éºãæããã¨ããäºã§ããããªã¼ã¹ã¯ã¼ã«ã«æ¥ã¦ããåéã®ã»ã¨ãã©ã¯é·æä¸ç»æ ¡ã§ãå¤ç¬ã«é¥ãããããä¸çãåºããã«ããäºãå¤ããã§ãããã ãã¾ãðºð¸ @readeigo 失é¡çãçè³é£è´ãå¤èª¤åãåºè¾ºé«âè²ã âðºð¸æé¢åãã«ãªãã©ã«ãã¢å·å¨ä½ãã¢ã©ãµã¼å¥³ã®ä¸é話ãã¢ã«ã¦ã³ãã¯ããã®ã¿ã§ããä»ã®ã¢ã«ã¦ã³ãã¯ç§ã§ã¯ããã¾ãããã¡ã³ã·ã§ã³
Mu COVID Variant That May Resist Vaccines Found in 49 U.S. States ï¼ã¾ã ææå ¨ä½ã«å ããæ¯çã¯å°ãªãããç¾å¨99ï¼ ãå ãããã«ã¿æ ªãæåã¯ããã ã£ãï¼ æ°åã³ããã¦ã¤ã«ã¹ã®å¤ç°æ ªã®ä¸ç¨®ã§ãã¯ã¯ãã³ã®å¹æãæ¸å°ããå¯è½æ§ãããã¨ããã¦ãããã¥ã¼æ ªãå ¨ç±³ã«åºãã£ã¦ãããææäºä¾ãã¾ã ãªãã®ã¯ããã©ã¹ã«å·ã ãã ã 1æã«åç±³ã³ãã³ãã¢ã§æ°ããªå¤ç°æ ªã¨ãã¦ç¹å®ããã¦ä»¥æ¥ããã¥ã¼æ ªã¯ãã¢ã¡ãªã«ãå«ã41ã®å½ã ã«æ¡æ£ãããææ確èªä»¶æ°ã®ãã¡ãã¥ã¼æ ªãå ããå²åã¯ã¾ã 1ï¼ æªæºã ããææåãé«ããã¯ã¯ãã³ãèªç¶å ç«ã®å¹æãæ¸å°ãããå¯è½æ§ããããã¨ãããä¿å¥å½å±ã¯ãã®å¤ç°æ ªã®ååã注è¦ãã¦ããã æ°åã³ããã¦ã¤ã«ã¹å¤ç°æ ªã«é¢ãããªã¼ãã³ã½ã¼ã¹ãã¼ã¿ãæä¾ãã¦ããã¦ã§ããµã¤ããOutbreak.infoãã®æ å ±ã«ããã¨ãããã©ã¹ã«å·ãé¤ãã¢ã¡
æ¥æ¬ã§éå¬ããã2016å¹´ã®å¤§ä¼ã§åªåããã¬ã¢ã«ã»ãããªã¼ãï¼ã¹ãã¤ã³ï¼ã®é¸æãã¡ï¼12æ18æ¥ãæ¥ç£ã¹ã¿ã¸ã¢ã æ¥æ¬ãµãã«ã¼åä¼ã12æã®ã¯ã©ãã¯ã¼ã«ãã«ããï¼Wæ¯ï¼ã®æ¥æ¬éå¬ãè¿ä¸ããæ¹éãåºãããã¨ã7æ¥ãè¤æ°ã®é¢ä¿è ã®è©±ã§åãã£ããæ°åã³ããã®å½±é¿ã§ãå½éãµãã«ã¼é£çï¼FIFAï¼ã¨åè°ãã¦ããã ãåçãWæ¯æçµäºé¸ãå å¶ã´ã¼ã«ã決ãåã¶å¤§è¿« æ¥æ¬åä¼åµç«100å¨å¹´ã®è¨å¿µäºæ¥ã®ä¸ç°ã§ã5å¹´ã¶ãã®å½å éå¬ã«åãæºåãã¦ãããæææ¡å¤§ãªã¹ã¯ã«å ã観客å¶éã«ããæ¡ç®é¢ãå³ãããæ¥æ¬ã§ã®å®æ½ã¯å°é£ã¨ã®çµè«ã«è³ã£ãã ã¯ã©ãä¸çä¸ã決ããã¯ã©ãWæ¯ã®ä»£æ¿éå¬å°ã¨ææã¯æµåçã§ãFIFAãæ¤è¨ãç¶ããã ã¯ã©ãWæ¯ãæ¥å¹´ã«ããè¾¼ãã§12æã®æ¥ç¨ã空ãã°ãåæ19æ¥ã«å¤©çæ¯å ¨æ¥æ¬é¸æ権決åãå®æ½ããæ¡ãæµ®ä¸ãã¦ããã
ãããã@å½éæ©é¢è·å¡ @Asaoki_UN ä¸çãµããçºè¦ã§ãã¼ãæ代ã®å¥´é·ã«ã¤ãã¦ãæ±å¤§ã®ææããè²´éãªåãæã¨ãã¦ãããªãã®å¾ éãåãã¦ãããçããã殺ãããåãæãå¢ããããã«åã©ããä½ã£ã¦æ¬²ããã¨ããå¾ éãä»ã§è¨ãã°ãµã©ãªã¼ãã³ã¿ãããªåå¨ãã£ã¦çµæ§åããã¨ããµã©ãã¨è¨ã£ã¦ã
æ±äº¬ã»ä¸ç°è°·åºãæ°åã³ããã¦ã¤ã«ã¹ã®å¾éºçã«ã¤ãã¦èª¿æ»ããã¨ãããææãã人ã®ãããåæ°ã«ããæ æãªã©ã®çç¶ããããã¨ããããã¾ãããä¸ã«ã¯å年以ä¸ãçç¶ãç¶ãã¦ãã人ãããããã§ãã æ°ã«ãªãçç¶ã®è©³ç´°ãã年代å¥ãªã©ã®æ å ±ãã¾ã¨ãã¾ããã ä¸ç°è°·åºã§ã¯ããã¨ã4æã®æç¹ã§æ°åã³ããã¦ã¤ã«ã¹ã§åºå ã®ç é¢ã«å ¥é¢ããæ£è ãèªå® çé¤ããåºæ°ãªã©ã対象ã«ãæ°åã³ããã¦ã¤ã«ã¹ã®å¾éºçã«é¢ããã¢ã³ã±ã¼ã調æ»ãè¡ãã¾ããã3710件ã®åçãå¾ã¾ããã å¾éºçã®æç¡ ããã«ããã¾ãã¨ãå¾éºçãããããã¨åçãã人ã¯å ¨ä½ã®åæ°è¿ãããã1800人ã«ã®ã¼ãã¾ããã
ã¢ãã¤ã«æ¥çã§ã¯ãéããªãçºè¡¨ãããã¨ã¿ããã次æiPhoneã注ç®ãéãã¦ããããä¸å¤æ¥çã§ã¯ããã¾ã ã«ãiPhone 8ãããiPhone 7ãã売ãçã¨ãªã£ã¦ãããä¸å¤æ¥è ãçºè¡¨ããã¹ãã¼ããã©ã³ã®è²©å£²ã©ã³ãã³ã°ãè¦ãã¨ãiPhone 8ãiPhone 7ãä¸ä½ãç¬å ãã¦ãããiPhone 8ã¯2017å¹´ãiPhone 7ã¯2016å¹´ã«çºå£²ãããã¢ãã«ã4ï½5å¹´ãåã«çºå£²ãããã¢ãã«ããä¸å¤ã¨ã¯ãããã¾ã ã«å£²ãã¦ãããã¨ã¯é©ãã ã âã²ãªã2021å¹´ä¸åæã®ä¸å¤ã¹ããã©ã³ãã³ã°çºè¡¨ãç·å1ä½ã¯ãiPhone 8ã ä»åãä¸å¤ã¹ãã¼ããã©ã³ãæ±ãã²ãªãã¼ã«ãã£ã³ã°ã¹ï¼ä»¥ä¸ãã²ãªï¼ã¨ãä¸å¤iPhoneãã¡ã¤ã³ã«æ±ããã«ãã¹ãããå±éãã¦ããBelongã®2社ã«ãä¸å¤iPhoneã®å£²ãçãã¬ã³ããèããã ä¸å¤ãªã1ä¸ï½2ä¸åå°ã§iPhoneãæã«å ¥ã ã¾ããã²ãªã強調ããã®ããã³ã¹ããã
ããã¾ã§ã®ç 究ã«ãããæ°åã³ããã¦ã¤ã«ã¹ã¯èºã ãã§ãªãå¿èãè èãªã©ã®èå¨ã«ãè¡æ ãçãããããã¨ãåãã£ã¦ãã¾ããããã«ãå¿èã®è¡ç®¡ã«ããç´°èãæ°åã³ããã¦ã¤ã«ã¹ã®ã¿ã³ãã¯è³ªã«ãããå®é¨ã«ãããç´æ¥ã¦ã¤ã«ã¹ã«ææãã¦ããªãå¿èã®ç´°èãã¦ã¤ã«ã¹ã®ã¿ã³ãã¯è³ªã«ãããã¡ã¼ã¸ãåããå¯è½æ§ããããã¨ã確èªããã¾ããã The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease | bioRxiv https://www.biorxiv.org/content/10.1101/2020.12.
ãã¤ã¦âãã£ãã·ã¥ã¬ã¹å¾é²å½âã¨è¨ãããæ¥æ¬ãè¿å¹´ã¯ã¯ã¬ã¸ããã«ã¼ããé»åããã¼ã®å©ç¨ãé²ã¿ããã©ã®ã«ã¼ãããå¾ï¼ãããã¤ã³ãéå çã¯ï¼ãã¨ãã£ãä¼è©±ãæ¥å¸¸ã®é¢¨æ¯ã«ãªãã¾ãããæ¥çã30年以ä¸åæãã¦ãã岩ç°æç·ããããâãã£ãã·ã¥ã¬ã¹çé¨æ²âãå·éã«è¦ã¤ããå©ç¹ãåé¡ç¹ãåæãã¾ãã çè ã¯ä»ç§ãã¯ã¬ã¸ããã«ã¼ãå社ãææ°æå¼ãä¸ãã«åãã¨ã¿ã¦ãã¾ãã å¾è¿°ãã¾ãããQRã³ã¼ã決æ¸æ大æã®PayPayã8æãç°ä¾ã®å®ãã¨ãªã決æ¸ææ°æãçºè¡¨ããããã§ãã ãã£ãã·ã¥ã¬ã¹æ±ºæ¸ã¨ããåãå俵ã§ç«¶åããã¯ã¬ã¸ããã«ã¼ãå社ã¯ãéããã«è¿½éããããå¾ãªãã¯ãã§ãã ä»åã¯ææ°æã®ç¾ç¶ã¨ä»å¾ã®å±æã«ã¤ãã¦è§£èª¬ãã¾ãã ç ´æ ¼ã«é«ãæ¥æ¬ã®ææ°æçãçµç£çã¯ä¸æº ãã£ãã·ã¥ã¬ã¹æ±ºæ¸æã®ãã¤ã³ãéå çãªã©ãè¨ããããã¹ã¿ã¼ãåºé ã«è²¼ãä¸èå¼æçµæ¸ç£æ¥ç¸ï¼å³ãå½æï¼ï¼2019å¹´8æãæ±äº¬é½æ並åºãææ¥æ°è社
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}